Effect of Red Clover on menopausal symptoms.

Evaluation of the effect of oral red clover drug on the severity of menopausal symptoms of 50-59 yeares old women attendant to menopausal clinic.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201112172172N13

Enrollment

110

Registered

2012-02-02

Start date

2011-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal symptoms. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention 1:Oral administration 40 mg Red clovercapsule, twice a day for 3 month. Intervention 2: Placebo Group: Capsule 50 mg containe starch, twice a day,for 3 monthes.

Treatment - Drugs

Placebo

Intervention 1:Oral administration 40 mg Red clovercapsule, twice a day for 3 month

Placebo Group: Capsule 50 mg containe starch, twice a day,for 3 monthes

Eligibility

Sex/Gender

Female

Age

50 Years to 59 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : naturally menopausal women, 50-59 years old; Negative history of cancer; Negative history of physical and psychological disease; Negative history of hormone therapy and herbal medicine; Negative history of allergy to Red Clover, Soy bean and other herbal medicine. Exclusion criteria: Under medication by hormone therapy, antibiotic or anti acid (due to inhibition of herbal medicine absorption); Starting any type of herbal medication more than once a week during the study; Starting vegetarian diet during the study; allergy to Red Clover during the intervention; Poor cooperation during the study Stop using Red Clover/placebo for 6 day in 1 month; Obese women with BMI>38kg/m2

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of Menopausal symptoms scores. Timepoint: Before intervention, at the end of first, second and third of intervention after intervention. Method of measurement: Menopausal Rating Scale.	—

Secondary

Measure	Time frame
Severity of physical symptom scores. Timepoint: Before intervention, at the end of first, second and third of intervention after intervention. Method of measurement: Menopausal Rating Scale.;Severity psychological symptome score. Timepoint: Before the intervention,at the end of first, second and third of intervention. Method of measurement: Menopause Rating Scale.;Severity of urogental symptom score. Timepoint: Before the intervention,at the end of first,second and third of intervention. Method of measurement: Menopause Rating Scale.	—

Measure

Time frame

Severity of physical symptom scores. Timepoint: Before intervention, at the end of first, second and third of intervention after intervention. Method of measurement: Menopausal Rating Scale.;Severity psychological symptome score. Timepoint: Before the intervention,at the end of first, second and third of intervention. Method of measurement: Menopause Rating Scale.;Severity of urogental symptom score. Timepoint: Before the intervention,at the end of first,second and third of intervention. Method of measurement: Menopause Rating Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin Taavoni

Nursing and Midwifery Faculty, Tehran University of Medical Sciences

staavoni14@yahoo.com staavoni@iums.ac.ir+98 21 6692 1228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026